Received: from WA1PEPF000099D0.eurprd04.prod.outlook.com (2603:10a6:803:78:cafe::81) by VI1PR09CA0098.outlook.office365.com (2603:10a6:803:78::21) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.406.12 via Frontend Transport; Tue, 15 Sep 2026 14:11:35 +0000 Received: from VI1PR09CA0098.eurprd09.prod.outlook.com (2603:10a6:803:78::21) by PAVPR02MB9865.eurprd02.prod.outlook.com (2603:10a6:102:311::20) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.406.12; Tue, 15 Sep 2026 14:11:35 +0000 Received: from westeu11-emailsignatures-cloud.codetwo.com (20.93.157.195) by WA1PEPF000099D0.mail.protection.outlook.com (10.167.242.24) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.428.7 via Frontend Transport; Tue, 15 Sep 2026 14:11:35 +0000 Received: from AS8PR07CU003.outbound.protection.outlook.com (40.93.65.55) by westeu11-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Tue, 15 Sep 2026 14:11:34 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f]) by GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f%6]) with mapi id 15.21.0406.007; Tue, 15 Sep 2026 14:11:30 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com (2603:10a6:150:318::18) by DB9PR02MB9897.eurprd02.prod.outlook.com (2603:10a6:10:456::20) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.428.9; Tue, 15 Sep 2026 14:11:30 +0000 Received: from PAVPR02MB9865.eurprd02.prod.outlook.com (2603:10a6:102:311::20) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Tue, 15 Sep 2026 14:11:39 +0000 From: "Andrus Varki - RA" To: "Info - SOM" Cc: =?utf-8?Q?K=C3=A4rolin_Jenas_-_RA?= References: <0b1142f2de5b4ee9b77a206ee9671966@ravimiamet.ee> In-Reply-To: Subject: =?utf-8?Q?Vs:_Eeln=C3=B5u_edastamine_koosk=C3=B5last?= =?utf-8?Q?amiseks_ja_arvamuse_avaldamiseks?= Date: Tue, 15 Sep 2026 17:11:30 +0300 Keywords: liivia Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_008B_01DD45BB.08752A00" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIOkpl4/ke9+WNmGnvinYgaN9pG2wEidV1AAvAO1mEBgZBMcAI+CNbTAO+NVD0CDMzEsQJQEHqMAmmhbPsBkr31NQKV9MT7AYq5QeICTOku5QGJFe/C Authentication-Results: spf=pass (sender IP is 20.93.157.195) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 15 Sep 2026 14:11:35.1528 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: dc61e8ac-85d7-484c-592a-08df13334037 X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GVXPR02MB12202:EE_|DB9PR02MB9897:EE_|WA1PEPF000099D0:EE_|PAVPR02MB9865:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: dc61e8ac-85d7-484c-592a-08df13334037 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|366016|82310400026|23010399003|35042699022|31052699007|39142699007|55112099003|22082099003|18002099003|13003099007|8096899003|56012099006|11063799006|4143699003|10067099003|41050700001; X-Forefront-Antispam-Report: CIP:20.93.157.195;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu11-emailsignatures-cloud.codetwo.com;PTR:westeu11-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(366016)(82310400026)(23010399003)(35042699022)(31052699007)(39142699007)(55112099003)(22082099003)(18002099003)(13003099007)(8096899003)(56012099006)(11063799006)(4143699003)(10067099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 15 Sep 2026 14:11:35.0890 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: dc61e8ac-85d7-484c-592a-08df13334037 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB9PR02MB9897 X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAVPR02MB9865 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.8954917 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0406.012 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: mDmVNHZKGsOmnWUtLp+he8PRcUdfRmIswN8NXUvnM2PFCGn3E1qEGSqx3l88mfv7+FIbQZl3mkFHKI8phgaEE2HFSli/TkuRWfgcL056Lq6t9A0H31n92JZ97kikczTxQOjwhodoSdCwmtfC0kYFVuaqt19WQyYqR4w840/8RW2UFoKwuDUVrAvf4x187/QveRUoZUmIaclCeLhrGbkEibKzsC2+XP2d6CZNbV7yGrbCvdT/jfVJJnADFAiHmXuaKffQJm/gQy4O9u6UWRo44x5ehSqWDnDiBSO8YMoHKeZKvnc12CxgMJ9hjZEevCec1klm5WsFEcFaw/uphPhDvwReSiqvAvc1+ZQldATBiRHwpgRj6sG2yBnV7t0l6Zo/KlJqkG5TnXKKQGYrNXTrY+2MzBc7LQGMUEydgi2t7R/SRKt5tOUQSmplkKsMRLgaAj0ajMCcR0g9IkC+Irb5btCntDfukvfj0RN/ZjCLEnIycUNDzCJ0SLLpdNWgX2tV4QdmHuW7Pz+aI0kKCTWLnaPHkriKveahLmi6DSYID5l8nm4RDauLSouXEn2MU1JC93YTRoPczIxDvz9d5bT3jbWcamfV72vd3drpT7xr6uHmHXttsEioXt+BzAEHUtSkuxmlCWCyarSpcC1J4F4w04iRwb9PVyzgvkXUoVklAgpUFOywYB6D3Ydt8AiyvRI9ItQh8v0NixsV5i6RCZgLzi2J2g3ikAAroIXD5qd5R8/5dGHLecoD3THMkJq002LqC23C0KfwBHreMks/MsN46ifrlz3Ca+0bak5E7MtVwsrY/BembG2xw11aZnRvdvX39CRVDO326xES5cVNhK7UHiDGKx2FF6Vrelo3Oqba9EHP/AV6rKLTfjRku7FMry1ThUvBckEL6CLMpaJMDLhP6A== Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 x-ms-exchange-organization-originalserveripaddress: 10.167.242.24 received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 20.93.157.195 as permitted sender) receiver=protection.outlook.com; client-ip=20.93.157.195; helo=westeu11-emailsignatures-cloud.codetwo.com; pr=C X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-MS-Has-Attach: X-MS-TNEF-Correlator: acceptlanguage: et-EE, en-US X-OlkEid: 000000004943FF4B2AE9BB419B4D9712F9BA8BFE070034AD76187591974DBF6C4F76951C873A010002000000000068E7CFE0145B3B499213B01F169BEE3900000000071A0000B1060A73663201478A6DE7F976D9D0A3 X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|366016|31052699007|23010399003|39142699007|55112099003|22082099003|18002099003|13003099007|8096899003|4143699003|10067099003|56012099006|11063799006|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GVXPR02MB12202.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(366016)(31052699007)(23010399003)(39142699007)(55112099003)(22082099003)(18002099003)(13003099007)(8096899003)(4143699003)(10067099003)(56012099006)(11063799006)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: DXbmXr3yg5Z559msZCwxCdLeiy9DDvwQlJSiEY1E5qGptE5rgSPz8u/ys5SMugtFBk2VyC3n4CqOm4KRPxedJchFO/NPahMhAcc6lUNZ3Jw6bUd2plTiCRZqPGLpFbnOIwycnLu5pzWKPP4b7DUpQlap/0xucomdxen6eDaaVQu9ZXeT4R8IK89f8mEgZ1/cUS34DrBf9n3zPlmZAEXcTJeaVLg099T6Mx8ba+qkcAq5ygSq8RHjSlovfdP/ACBmrFoQ+XoChxHaor3hDm4v/oZNbcJp6G4IBMtrm/e0tlg9KiXaXwIF93st7XU5hg0OjBd8v7zXgcX6fp3Bb+zjyw== X-MS-Exchange-Transport-CrossTenantHeadersStripped: WA1PEPF000099D0.eurprd04.prod.outlook.com X-MS-Office365-Filtering-Correlation-Id-Prvs: da945a91-a402-42bb-179f-08df13333d7a X-OrganizationHeadersPreserved: DB9PR02MB9897.eurprd02.prod.outlook.com X-CodeTwo-MessageID: c41f4832-33a6-4907-b21c-af2de111f8c5.20260915141134@westeu11-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-CrossPremisesHeadersPromoted: WA1PEPF000099D0.eurprd04.prod.outlook.com X-CrossPremisesHeadersFiltered: WA1PEPF000099D0.eurprd04.prod.outlook.com X-OriginatorOrg: eegovg01.onmicrosoft.com X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[20.93.157.195];Helo=[westeu11-emailsignatures-cloud.codetwo.com] msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-09-15T14:11:29.992Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; This is a multipart message in MIME format. ------=_NextPart_000_008B_01DD45BB.08752A00 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Teie:    31.08.2026 nr 1.2-3/81-1 Meie:   15.09.2026 nr JUR-3/4688-2 Tere Ravimiametil ei ole märkuseid või ettepanekuid eelnõule. Lugupidamisega Andrus Varki juhataja Õigusosakond Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_008B_01DD45BB.08752A00 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable

Teie:=E2=80=82=E2=80=82=E2=80=82=E2=80=8231.08.2026 nr 1.2-3/81-1
Meie:=E2=80=82=E2=80=82=E2=80=8215.09.2026 nr JUR-3/4688-2


Tere

Ravimiametil ei ole m=C3=A4rkuseid v=C3=B5i ettepanekuid = eeln=C3=B5ule.



Lugupidamisega

Andrus Varki

juhataja

=C3=95igusosakond


Ravimiamet

737 4140

www.ravimiamet.ee


Selles = e-kirjas sisalduv teave (kaasa arvatud manused) on m=C3=B5eldud = ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja = adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt = v=C3=A4ljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. = Juhul, kui Te olete saanud k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, = teavitage sellest koheselt saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 



 

------=_NextPart_000_008B_01DD45BB.08752A00--